Literature DB >> 23582879

Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature.

Guillaume Ploussard1, Alberto Briganti, Alexandre de la Taille, Alexander Haese, Axel Heidenreich, Mani Menon, Tullio Sulser, Ashutosh K Tewari, James A Eastham.   

Abstract

CONTEXT: Pelvic lymph node dissection (PLND) in prostate cancer is the most effective method for detecting lymph node metastases. However, a decline in the rate of PLND during radical prostatectomy (RP) has been noted. This is likely the result of prostate cancer stage migration in the prostate-specific antigen-screening era, and the introduction of minimally invasive approaches such as robot-assisted radical prostatectomy (RARP).
OBJECTIVE: To assess the efficacy, limitations, and complications of PLND during RARP. EVIDENCE ACQUISITION: A review of the literature was performed using the Medline, Scopus, and Web of Science databases with no restriction of language from January 1990 to December 2012. The literature search used the following terms: prostate cancer, radical prostatectomy, robot-assisted, and lymph node dissection. EVIDENCE SYNTHESIS: The median value of nodal yield at PLND during RARP ranged from 3 to 24 nodes. As seen in open and laparoscopic RP series, the lymph node positivity rate increased with the extent of dissection during RARP. Overall, PLND-only related complications are rare. The most frequent complication after PLND is symptomatic pelvic lymphocele, with occurrence ranging from 0% to 8% of cases. The rate of PLND-associated grade 3-4 complications ranged from 0% to 5%. PLND is associated with increased operative time. Available data suggest equivalence of PLND between RARP and other surgical approaches in terms of nodal yield, node positivity, and intraoperative and postoperative complications.
CONCLUSIONS: PLND during RARP can be performed effectively and safely. The overall number of nodes removed, the likelihood of node positivity, and the types and rates of complications of PLND are similar to pure laparoscopic and open retropubic procedures.
Copyright © 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lymph node dissection; Prostate cancer; Radical prostatectomy; Robot assisted

Mesh:

Year:  2013        PMID: 23582879     DOI: 10.1016/j.eururo.2013.03.057

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  44 in total

Review 1.  Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients.

Authors:  Alessandro Conti; Matteo Santoni; Luciano Burattini; Marina Scarpelli; Roberta Mazzucchelli; Andrea B Galosi; Liang Cheng; Antonio Lopez-Beltran; Alberto Briganti; Francesco Montorsi; Rodolfo Montironi
Journal:  World J Urol       Date:  2015-12-22       Impact factor: 4.226

2.  Body mass index is an independent predictor of Clavien-Dindo grade 3 complications in patients undergoing robot assisted radical prostatectomy with extensive pelvic lymph node dissection.

Authors:  Antonio Benito Porcaro; Marco Sebben; Alessandro Tafuri; Nicolò de Luyk; Paolo Corsi; Tania Processali; Marco Pirozzi; Riccardo Rizzetto; Nelia Amigoni; Daniele Mattevi; Maria A Cerruto; Matteo Brunelli; Giovanni Novella; Vincenzo De Marco; Filippo Migliorini; Walter Artibani
Journal:  J Robot Surg       Date:  2018-05-08

3.  Fluorescence-Based Molecular Imaging of Porcine Urinary Bladder Sentinel Lymph Nodes.

Authors:  Hak J Lee; Christopher V Barback; Carl K Hoh; Zhengtao Qin; Kareem Kader; David J Hall; David R Vera; Christopher J Kane
Journal:  J Nucl Med       Date:  2017-02-02       Impact factor: 10.057

4.  Extended pelvic lymphadenectomy in prostate cancer: Practice makes perfect.

Authors:  Axel Heidenreich; David Pfister
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

5.  Multicenter evaluation of guideline adherence for pelvic lymph node dissection in patients undergoing open retropubic vs. laparoscopic or robot assisted radical prostatectomy according to the recent German S3 guideline on prostate cancer.

Authors:  Angelika Borkowetz; Johannes Bruendl; Martin Drerup; Jonas Herrmann; Hendrik Isbarn; Burkhard Beyer
Journal:  World J Urol       Date:  2018-02-09       Impact factor: 4.226

6.  Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection.

Authors:  Giorgio Brembilla; Paolo Dell'Oglio; Armando Stabile; Alessandro Ambrosi; Giulia Cristel; Lisa Brunetti; Anna Damascelli; Massimo Freschi; Antonio Esposito; Alberto Briganti; Francesco Montorsi; Alessandro Del Maschio; Francesco De Cobelli
Journal:  Eur Radiol       Date:  2017-12-21       Impact factor: 5.315

Review 7.  Complications of Minimally Invasive Surgery and Their Management.

Authors:  Joshua R Kaplan; Ziho Lee; Daniel D Eun; Adam C Reese
Journal:  Curr Urol Rep       Date:  2016-06       Impact factor: 3.092

8.  Peritoneal Flap in Robot-Assisted Radical Prostatectomy.

Authors:  Johannes Bründl; Sebastian Lenart; Gjoko Stojanoski; Christian Gilfrich; Bernd Rosenhammer; Michael Stolzlechner; Anton Ponholzer; Christina Dreissig; Steffen Weikert; Maximilian Burger; Matthias May
Journal:  Dtsch Arztebl Int       Date:  2020-04-03       Impact factor: 5.594

9.  Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan.

Authors:  Shuichi Morizane; Masashi Honda; Satoshi Fukasawa; Atsushi Komaru; Junichi Inokuchi; Masatoshi Eto; Masaki Shimbo; Kazunori Hattori; Yoshiaki Kawano; Atsushi Takenaka
Journal:  Int J Clin Oncol       Date:  2017-12-11       Impact factor: 3.402

10.  Microbiological evaluation of infected pelvic lymphocele after robotic prostatectomy: potential predictors for culture positivity and selection of the best empirical antimicrobial therapy.

Authors:  Alaa Hamada; Catalina Hwang; Jorge Fleisher; Ingolf Tuerk
Journal:  Int Urol Nephrol       Date:  2017-04-24       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.